State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, Hubei, China.
Hubei Key Laboratory of Environmental and Health Effects of Persistent Toxic Substances, School of Environment and Health, Jianghan University, Wuhan, 430056, China.
J Nanobiotechnology. 2024 Sep 28;22(1):586. doi: 10.1186/s12951-024-02846-1.
Lymph node metastasis (LNM) is a typical marker in oral squamous cell carcinoma (OSCC) indicating poor prognosis. Pathological examination by artificial image acquisition and analysis, as the main diagnostic method for LNM, often takes a week or longer which may cause great anxiety of the patient and also retard timely treatment. However, there are few efficient fast LNM diagnosis methods in clinical applications currently. Our previous study profiled the proteomics of extracellular vesicles (EVs) derived from postoperative drainage fluid (PDF) and showed the potential of detecting specific EVs that expressed aspartate β-hydroxylase (ASPH) for LNM diagnosis in OSCC patients. Considering that the analysis of ASPH PDF-EVs is challenging due to their low abundance (counting less than 10% of total EVs in PDF) and the complex EV isolation process of ultra-centrifugation, we developed a facile platform containing two microfluidic chips filled with antibody-modified microbeads to isolate ASPH PDF-EVs, with both the capture and retrieval rate reaching around 90%. Clinical sample analysis based on our method revealed that a mean of 6 × 10 /mL ASPH PDF-EVs could be isolated from LNM OSCC patients compared to 2.5 × 10 /mL in LNM OSCC ones. When combined with enzyme-linked immunosorbent assay (ELISA) technique that was commonly used in clinical laboratories in hospitals, this microfluidic platform could precisely distinguish postoperative OSCC patients with LNM or not in several hours, which were validated by a double-blind test containing 6 OSCC patients. We believe this strategy has promise for early diagnosis of LNM in postoperative OSCC patients and finally helps guiding timely and reasonable treatment in clinic.
淋巴结转移 (LNM) 是口腔鳞状细胞癌 (OSCC) 的典型标志物,预示着不良预后。人工采集和分析图像的病理检查是 LNM 的主要诊断方法,通常需要一周或更长时间,这可能会给患者带来极大的焦虑,也会延误及时的治疗。然而,目前临床上很少有有效的快速 LNM 诊断方法。我们之前的研究对来自术后引流液 (PDF) 的细胞外囊泡 (EVs) 的蛋白质组学进行了分析,并显示了检测表达天冬氨酸 β-羟化酶 (ASPH) 的特定 EVs 用于 OSCC 患者 LNM 诊断的潜力。由于 ASPH PDF-EVs 的丰度低(在 PDF 中的总 EVs 中占比不到 10%)且超速离心等复杂的 EV 分离过程,因此分析 ASPH PDF-EVs 具有挑战性,我们开发了一个包含两个充满抗体修饰微珠的微流控芯片的简便平台来分离 ASPH PDF-EVs,捕获和回收效率均达到 90%左右。基于我们的方法对临床样本的分析表明,与 LNM OSCC 患者相比,LNM OSCC 患者的 ASPH PDF-EVs 平均可以分离出 6×10 /mL,而 LNM OSCC 患者的 ASPH PDF-EVs 平均可以分离出 2.5×10 /mL。当与医院临床实验室常用的酶联免疫吸附测定 (ELISA) 技术结合使用时,该微流控平台可以在数小时内精确区分术后 OSCC 患者是否有 LNM,这通过包含 6 名 OSCC 患者的双盲测试得到了验证。我们相信,这种策略有望用于早期诊断术后 OSCC 患者的 LNM,最终有助于指导临床及时合理治疗。